Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05036369 · ClinicalTrials.gov registry record · NA
Vibrant Capsule vs. Placebo for Patient Suffering From Constipation
A NA study, sponsored by Vibrant.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05036369: Completed NA study, sponsored by Vibrant.
NCT05036369 is a NA study that has completed, run by Vibrant. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05036369, a NA study, has completed, sponsored by Vibrant.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The objectives are to assess the efficacy and safety of Vibrant capsule administered twice a week
Primary Outcome
CSBM1 Success Rate: defined as the number of Participants with an increase from the run-in period of at least one weekly Complete Spontaneous Bowel Movement (CSBM) during at least 6 of the 8 weeks of treatment. NOTE: A spontaneous bowel movement (SBM) is defined as a bowel movement that occurs at least 48h after laxative/rescue intake and without digital maneuver. A complete spontaneous bowel movement (CSBM) is defined as a spontaneous bowel movement associated with a feeling of complete evac
Interventions
- DEVICE Vibrant capsule
- DEVICE Placebo capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-07-05 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
What the finished NCT05036369 record still lists
NCT05036369 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Vibrant capsule is the first listed.
NCT05036369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05036369 about?
NCT05036369 is a clinical study titled "Vibrant Capsule vs. Placebo for Patient Suffering From Constipation". The objectives are to assess the efficacy and safety of Vibrant capsule administered twice a week
What is the current status of trial NCT05036369?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-07-05. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT05036369?
The interventions under investigation include: Vibrant capsule (DEVICE), Placebo capsule (DEVICE).
Who is sponsoring clinical trial NCT05036369?
This trial is sponsored by Vibrant, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05036369's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI